Stockreport

Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA™ (eravacycline) for the Treatment of Complic...

TETRAPHASE PHARMACEUTICALS INC  (TTPH) 
Last tetraphase pharmaceuticals inc earnings: 3/11 09:29 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tphase.com/investor-relations
PDF – Broad Product Label for Treatment of Complicated Intra-Abdominal Infections – – Phased Commercial Launch Expected in the First Half of 2019 – WATERTOWN, Mass., Sept. [Read more]